Rhumatoid Arthisis study: SFR application
Official title Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis
ClinicalTrials.gov ID: NCT07460739
What this study is testing
- What it's testing
- Rheumatoid arthritis (RA) and spondyloarthritis (SpA), including psoriatic arthritis (PsA), are chronic painful diseases that impair quality of life.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age between 18 and 75 years
- Diagnosis of rheumatoid arthritis (RA) according to the 2010 ACR/EULAR classification criteria of the American College of Rheumatology, or axial or...
- Undergoing a treatment change to a tDMARD (biologic or JAK inhibitor) available in the SFR application.
- No therapeutic education on tDMARDs in the past two years.
- Ability to use a smartphone application.
You likely can't join if
- Any condition that may affect comprehension or treatment adherence (chronic alcoholism, language barrier, severe psychiatric disorders, cognitive...
- Planned treatment with intravenous bDMARDs in the upcoming year.
- Patients who have already downloaded self-management applications for their rheumatic disease.
- Patients enrolled in a therapeutic education program: face-to-face education by a nurse or healthcare professional, or group education.
- Patients who have already received therapeutic education on targeted DMARDs in the past two years: face-to-face education by a nurse or healthcare...
- Participation in another treatment clinical trial
See the full eligibility criteria
- Age between 18 and 75 years
- Diagnosis of rheumatoid arthritis (RA) according to the 2010 ACR/EULAR classification criteria of the American College of Rheumatology, or axial or peripheral spondyloarthritis (SpA) according to the 2009 ASAS criteria...
- Undergoing a treatment change to a tDMARD (biologic or JAK inhibitor) available in the SFR application.
- No therapeutic education on tDMARDs in the past two years.
- Ability to use a smartphone application.
- Ability to use a website.
- Ability to complete a questionnaire.
- Signed informed consent for the study.
- Covered by social security or entitled to social protection.
- Any condition that may affect comprehension or treatment adherence (chronic alcoholism, language barrier, severe psychiatric disorders, cognitive impairment).
- Planned treatment with intravenous bDMARDs in the upcoming year.
- Patients who have already downloaded self-management applications for their rheumatic disease.
- Patients enrolled in a therapeutic education program: face-to-face education by a nurse or healthcare professional, or group education.
- Patients who have already received therapeutic education on targeted DMARDs in the past two years: face-to-face education by a nurse or healthcare professional, or group education.
- Participation in another treatment clinical trial
- Pregnant or breast-feeding woman
- Individual under legal protection (tutorship or guardianship) or deprived of freedom
The study team makes the final eligibility decision.
Where it is enrolling
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Paris, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.